Cargando…
Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis
Bone infection contributing to inflammatory osteolysis is common in orthopedic surgery. The dynamic balance between bone formation and bone resorption is destroyed due to excessive osteoclast fusion and differentiation, which results in severe bone matrix loss. Many therapeutic approaches that restr...
Autores principales: | Chen, Yueqi, Wang, Yiran, Tang, Ruohui, Yang, Jing, Dou, Ce, Dong, Yutong, Sun, Dong, Zhang, Chengmin, Zhang, Lincheng, Tang, Yong, Dai, Qijie, Luo, Fei, Xu, Jianzhong, Dong, Shiwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265503/ https://www.ncbi.nlm.nih.gov/pubmed/32488049 http://dx.doi.org/10.1038/s41419-020-2612-z |
Ejemplares similares
-
Interleukin‐37 inhibits osteoclastogenesis and alleviates inflammatory bone destruction
por: Tang, Ruohui, et al.
Publicado: (2018) -
A selected small molecule prevents inflammatory osteolysis through restraining osteoclastogenesis by modulating PTEN activity
por: Chen, Yueqi, et al.
Publicado: (2020) -
The role of dendritic cells derived osteoclasts in bone destruction diseases
por: Wang, Bo, et al.
Publicado: (2020) -
Sphingosine‐1‐phosphate (S1P) receptors: Promising drug targets for treating bone‐related diseases
por: Zhang, Lincheng, et al.
Publicado: (2020) -
Epothilone B prevents lipopolysaccharide-induced inflammatory osteolysis through suppressing osteoclastogenesis via STAT3 signaling pathway
por: Chen, Yueqi, et al.
Publicado: (2020)